VST Bio is a biotechnology company that offers and develops treatment for vascular diseases.
VST Bio has raised $16.1M in total funding. The most recent round was Series A. The last funding was announced in March 2026.
VST Bio's investors include Coefficient Giving.
VST Bio is headquartered in San Diego, United States.
VST Bio is a biotechnology company that offers and develops treatment for vascular diseases.
VST Bio is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"VST Bio — Funding & Investors." VCBacked, March 17, 2026, https://www.vcbacked.co/company/vst-bio. Accessed August 14, 2026.
VCBacked. (2026). VST Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/vst-bio
{{cite web |title=VST Bio — Funding & Investors |url=https://www.vcbacked.co/company/vst-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated